Glucocorticoids and bone: consequences of endogenous and exogenous excess and replacement therapy

Multilineage potential of adult human mesenchymal stem cells

Pittenger, M. F., Mackay, A. M., Beck, S. C., Jaiswal, R. K., Douglas, R., Mosca, J. D., Moorman, M. A., Simonetti, D. W., Craig, S., & Marshak, D. R. (1999) · Science · doi:10.1126/science.284.5411.143 · Cited by 21,052 · see citing works

Mesenchymal stem cells

Caplan, A. I. (1991) · Journal of Orthopaedic Research® · doi:10.1002/jor.1100090504 · Cited by 6,563 · see citing works

Vertebral fracture assessment using a semiquantitative technique

Genant, H. K., Wu, C. Y., van Kuijk, C., & Nevitt, M. C. (1993) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650080915 · Cited by 3,691 · see citing works

Birth and Death of Bone Cells: Basic Regulatory Mechanisms and Implications for the Pathogenesis and Treatment of Osteoporosis

Manolagas, S. C. (2000) · Endocrine Reviews · doi:10.1210/edrv.21.2.0395 · Cited by 2,575 · see citing works

Endocrine regulation of energy metabolism by the skeleton

Lee, N. K., Sowa, H., Hinoi, E., Ferron, M., Ahn, J. D., Confavreux, C., Dacquin, R., Mee, P. J., McKee, M. D., Jung, D. Y., et al. (2007) · Cell · doi:10.1016/j.cell.2007.05.047 · Cited by 2,554 · see citing works

Osteogenic differentiation of purified, culture-expanded human mesenchymal stem cells in vitro

Jaiswal, N., Haynesworth, S. E., Caplan, A. I., & Bruder, S. P. (1997) · Journal of Cellular Biochemistry · doi:10.1002/(sici)1097-4644(199702)64:2 · Cited by 2,547 · see citing works

WNT signaling in bone homeostasis and disease: From human mutations to treatments

Baron, R., & Kneissel, M. (2013) · Nature Medicine · doi:10.1038/nm.3074 · Cited by 2,093 · see citing works

Evidence for osteocyte regulation of bone homeostasis through RANKL expression

Nakashima, T., Hayashi, M., Fukunaga, T., Kurata, K., Oh-hora, M., Feng, J. Q., Bonewald, L. F., Kodama, T., Wutz, A., Wagner, E. F., et al. (2011) · Nature Medicine · doi:10.1038/nm.2452 · Cited by 1,778 · see citing works

Cushing's syndrome

Lacroix, A., Feelders, R. A., Stratakis, C. A., & Nieman, L. K. (2015) · The Lancet · doi:10.1016/s0140-6736(14)61375-1 · Cited by 1,777 · see citing works

Inhibition of osteoblastogenesis and promotion of apoptosis of osteoblasts and osteocytes by glucocorticoids. Potential mechanisms of their deleterious effects on bone.

Weinstein, R. S., Jilka, R. L., Parfitt, A. M., & Manolagas, S. C. (1998) · Journal of Clinical Investigation · doi:10.1172/jci2799 · Cited by 1,753 · see citing works

Mortality Risk Associated With Low-Trauma Osteoporotic Fracture and Subsequent Fracture in Men and Women

Bliuc, D. (2009) · JAMA · doi:10.1001/jama.2009.50 · Cited by 1,695 · see citing works

Management of adrenal incidentalomas: European society of endocrinology clinical practice guideline in collaboration with the European network for the study of adrenal tumors

Fassnacht, M., Arlt, W., Bancos, I., Dralle, H., Newell-Price, J., Sahdev, A., Tabarin, A., Terzolo, M., Tsagarakis, S., & Dekkers, O. M. (2016) · European Journal of Endocrinology · doi:10.1530/eje-16-0467 · Cited by 1,566 · see citing works

Use of Inhaled Corticosteroids and Risk of Fractures

van Staa, T. P., Leufkens, H. G. M., & Cooper, C. C. (2001) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2001.16.3.581 · Cited by 1,297 · see citing works

Dickkopf-1 is a master regulator of joint remodeling

Diarra, D., Stolina, M., Polzer, K., Zwerina, J., Ominsky, M. S., Dwyer, D., Korb, A., Smolen, J. S., Hoffmann, M. H., Scheinecker, C., et al. (2007) · Nature Medicine · doi:10.1038/nm1538 · Cited by 1,296 · see citing works

Use of oral corticosteroids and risk of fractures

Van Staa, T. P., Leufkens, H. G. M., Abenhaim, L., Zhang, B., & Cooper, C. (2000) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2000.15.6.993 · Cited by 1,263 · see citing works

Alendronate for the Prevention and Treatment of Glucocorticoid-Induced Osteoporosis

Saag, K. G., Emkey, R., Schnitzer, T. J., Brown, J. P., Hawkins, F., Goemaere, S., Thamsborg, G., Liberman, U. A., Delmas, P. D., Malice, M.-P., et al. (1998) · New England Journal of Medicine · doi:10.1056/nejm199807303390502 · Cited by 1,258 · see citing works

The Osteocyte: An Endocrine Cell … and More

Dallas, S. L., Prideaux, M., & Bonewald, L. F. (2013) · Endocrine Reviews · doi:10.1210/er.2012-1026 · Cited by 1,042 · see citing works

Increased bone formation by prevention of osteoblast apoptosis with parathyroid hormone

Jilka, R. L., Weinstein, R. S., Bellido, T., Roberson, P. K., PARFITT, A. M., & Manolagas, S. C. (1999) · Journal of Clinical Investigation · doi:10.1172/jci6610 · Cited by 1,042 · see citing works

Teriparatide or Alendronate in Glucocorticoid-Induced Osteoporosis

Saag, K. G., Shane, E., Boonen, S., Marín, F., Donley, D. W., Taylor, K. A., Dalsky, G. P., & Marcus, R. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa071408 · Cited by 914 · see citing works

Growth Hormone, Insulin-Like Growth Factors, and the Skeleton

Giustina, A., Mazziotti, G., & CANALIS, E. M. (2008) · Endocrine Reviews · doi:10.1210/er.2007-0036 · Cited by 910 · see citing works

Prevention of osteocyte and osteoblast apoptosis by bisphosphonates and calcitonin

Plotkin, L. I., Weinstein, R. S., Parfitt, A. M., Roberson, P. K., Manolagas, S. C., & Bellido, T. (1999) · Journal of Clinical Investigation · doi:10.1172/jci6800 · Cited by 890 · see citing works

11β-hydroxysteroid dehydrogenases: Intracellular gate-keepers of tissue glucocorticoid action

Chapman, K., Holmes, M., & Seckl, J. (2013) · Physiological Reviews · doi:10.1152/physrev.00020.2012 · Cited by 887 · see citing works

11β-Hydroxysteroid dehydrogenase type 1 knockout mice show attenuated glucocorticoid-inducible responses and resist hyperglycemia on obesity or stress

Kotelevtsev, Y. V., Holmes, M. C., Burchell, A. N., Houston, P., Schmoll, D., Jamieson, P. M., Best, R., Brown, R., Edwards, C. R. W., Seckl, J. R., et al. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.26.14924 · Cited by 858 · see citing works

The Basophil Adenomas of the Pituitary Body and Their Clinical Manifestations (Pituitary Basophilism)

Cushing, H. (1964) · Journal of neurosurgery · doi:10.3171/jns.1964.21.4.0318 · Cited by 849 · see citing works

UK clinical guideline for the prevention and treatment of osteoporosis

The National Osteoporosis Guideline Group (NOGG), Compston, J. E., Cooper, A., Cooper, C. C., Gittoes, N. J. L., Gregson, C. L., Harvey, N. C., Hope, S., Kanis, J. А., McCloskey, E. V., et al. (2017) · Archives of Osteoporosis · doi:10.1007/s11657-017-0324-5 · Cited by 837 · see citing works

Short term use of oral corticosteroids and related harms among adults in the United States: population based cohort study

Waljee, A. K., Rogers, M. A. M., Lin, P., Singal, A. G., Stein, J. D., Marks, R. M., Ayanian, J. Z., & Nallamothu, B. K. (2017) · BMJ · doi:10.1136/bmj.j1415 · Cited by 830 · see citing works

The Effect of Glucocorticoids on Joint Destruction in Rheumatoid Arthritis

Kirwan, J. R. (1995) · New England Journal of Medicine · doi:10.1056/nejm199507203330302 · Cited by 817 · see citing works

Stimulation of Osteoprotegerin Ligand and Inhibition of Osteoprotegerin Production by Glucocorticoids in Human Osteoblastic Lineage Cells: Potential Paracrine Mechanisms of Glucocorticoid-Induced Osteoporosis1

Hofbauer, L. C., Gori, F., Riggs, B. L., Lacey, D. L., Dunstan, C. R., Spelsberg, T. C., & Khosla, S. (1999) · Endocrinology · doi:10.1210/endo.140.10.7034 · Cited by 794 · see citing works

Glucocorticoids Act Directly on Osteoblasts and Osteocytes to Induce Their Apoptosis and Reduce Bone Formation and Strength

O’Brien, C. A., Jia, D., Plotkin, L. I., Bellido, T., Powers, C. C., Stewart, S. A., Manolagas, S. C., & Weinstein, R. S. (2003) · Endocrinology · doi:10.1210/en.2003-0990 · Cited by 771 · see citing works

11β-Hydroxysteroid Dehydrogenase

Stewart, P. M., & Krozowski, Z. S. (1997) · Vitamins and hormones · doi:10.1016/s0083-6729(08)60646-9 · Cited by 716 · see citing works

Interactions between the Hypothalamic-Pituitary-Adrenal Axis and the Female Reproductive System: Clinical Implications

Chrousos, G. P., Torpy, D. J., & Gold, P. W. (1998) · Annals of Internal Medicine · doi:10.7326/0003-4819-129-3-199808010-00012 · Cited by 707 · see citing works

Oral corticosteroids and fracture risk: relationship to daily and cumulative doses

van Staa, T. P., Leufkens, H. G. M., Abenhaim, L., Zhang, B., & Cooper, C. C. (2000) · Lara D. Veeken · doi:10.1093/rheumatology/39.12.1383 · Cited by 699 · see citing works

Intermittent Etidronate Therapy to Prevent Corticosteroid-Induced Osteoporosis

Adachi, J. D., Bensen, W., Brown, J. P., Hanley, D. A., Hodsman, A. B., Josse, R. G., Kendler, D. L., Lentle, B. C., Olszynski, W. P., Ste‐Marie, L., et al. (1997) · New England Journal of Medicine · doi:10.1056/nejm199708073370603 · Cited by 683 · see citing works

Differentiation of human bone marrow osteogenic stromal cells in vitro: induction of the osteoblast phenotype by dexamethasone

Cheng, S., Yang, J., Rifas, L., Zhang, S. F., & Avioli, L. V. (1994) · Endocrinology · doi:10.1210/endo.134.1.8275945 · Cited by 647 · see citing works

COBRA combination therapy in patients with early rheumatoid arthritis: Long‐term structural benefits of a brief intervention

Landewé, R., Boers, M., Verhoeven, A. C., Westhovens, R., van de Laar, M. A. F. J., Markusse, H. M., van Denderen, J. C., Westedt, M. L., Peeters, A. J., Dijkmans, B. A. C., et al. (2002) · Arthritis & Rheumatism · doi:10.1002/art.10083 · Cited by 611 · see citing works

2017 American College of Rheumatology Guideline for the Prevention and Treatment of Glucocorticoid‐Induced Osteoporosis

Buckley, L. M., Guyatt, G. H., Fink, H. A., Cannon, M. D., Grossman, J., Hansen, K. E., Humphrey, M. B., Lane, N. E., Magrey, M., Miller, M. A., et al. (2017) · Arthritis Care & Research · doi:10.1002/acr.23279 · Cited by 578 · see citing works

Therapeutic Mechanisms of Glucocorticoids

Vandewalle, J., Luypaert, A., Bosscher, K. D., & Libert, C. (2017) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2017.10.010 · Cited by 554 · see citing works

Use of oral corticosteroids in the United Kingdom

van Staa, T. P. (2000) · QJM · doi:10.1093/qjmed/93.2.105 · Cited by 529 · see citing works

Zoledronic acid and risedronate in the prevention and treatment of glucocorticoid-induced osteoporosis (HORIZON): a multicentre, double-blind, double-dummy, randomised controlled trial

Reid, D. M., Devogelaer, J.-P., Saag, K., Roux, C., Lau, C.-S., Reginster, J.-Y., Papanastasiou, P., Ferreira, A., Hartl, F., Fashola, T., et al. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60250-6 · Cited by 527 · see citing works

2017 American College of Rheumatology Guideline for the Prevention and Treatment of Glucocorticoid‐Induced Osteoporosis

Buckley, L. M., Guyatt, G. H., Fink, H. A., Cannon, M. D., Grossman, J., Hansen, K. E., Humphrey, M. B., Lane, N. E., Magrey, M., Miller, M. A., et al. (2017) · Arthritis & Rheumatology · doi:10.1002/art.40137 · Cited by 527 · see citing works

Parathyroid hormone treatment can reverse corticosteroid-induced osteoporosis. Results of a randomized controlled clinical trial.

Lane, N. E., Sanchez, S., Modin, G. W., Genant, H. K., Pierini, E., & Arnaud, C. D. (1998) · Journal of Clinical Investigation · doi:10.1172/jci3914 · Cited by 526 · see citing works

Effects of Risedronate Treatment on Bone Density and Vertebral Fracture in Patients on Corticosteroid Therapy

Wallach, S., Cohen, S. B., Reid, D. M., Hughes, R., Hosking, D. J., Laan, R., Doherty, S. M., Maricic, M. J., Rosen, C. J., Brown, J. P., et al. (2000) · Calcified Tissue International · doi:10.1007/s002230001146 · Cited by 512 · see citing works

Development of prognostic nomograms for individualizing 5-year and 10-year fracture risks

Nguyen, N. D., Frost, S. A., Eisman, J. A., & Nguyen, T. V. (2008) · Osteoporosis International · doi:10.1007/s00198-008-0588-0 · Cited by 428 · see citing works

Glucocorticoids suppress bone formation by attenuating osteoblast differentiation via the monomeric glucocorticoid receptor.

Rauch, A., Seitz, S., Baschant, U., Schilling, A., Illing, A., Stride, B. D., Kirilov, M., Mandic, V., Takacz, A., Schmidt-Ullrich, R., et al. (2010) · Cell Metabolism · doi:10.1016/j.cmet.2010.05.005 · Cited by 423 · see citing works

Prevalence of oral glucocorticoid usage in the United States: a general population perspective

Overman, R. A., Yeh, J., & Deal, C. L. (2013) · Arthritis Care & Research · doi:10.1002/acr.21796 · Cited by 405 · see citing works

Apoptosis of Osteocytes in Glucocorticoid-Induced Osteonecrosis of the Hip 1

Weinstein, R. S., Nicholas, R. W., & Manolagas, S. C. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.8.6714 · Cited by 397 · see citing works

Promotion of osteoclast survival and antagonism of bisphosphonate-induced osteoclast apoptosis by glucocorticoids

Weinstein, R. S., Chen, J., Powers, C. C., Stewart, S. A., Landes, R. D., Bellido, T., Jilka, R. L., PARFITT, A. M., & Manolagas, S. C. (2002) · Journal of Clinical Investigation · doi:10.1172/jci14538 · Cited by 396 · see citing works

Glucocorticoids Act Directly on Osteoclasts to Increase Their Life Span and Reduce Bone Density

Jia, D., O’Brien, C. A., Stewart, S. A., Manolagas, S. C., & Weinstein, R. S. (2006) · Endocrinology · doi:10.1210/en.2006-0459 · Cited by 394 · see citing works

Use of Type I Collagen Green Fluorescent Protein Transgenes to Identify Subpopulations of Cells at Different Stages of the Osteoblast Lineage

Kalajzić, I., Kalajzić, Ž., Kaliterna, M., Gronowicz, G., Clark, S. H., Lichtler, A. C., & Rowe, D. W. (2002) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2002.17.1.15 · Cited by 392 · see citing works

Differentiation of Osteoblasts and in Vitro Bone Formation from Murine Embryonic Stem Cells

Buttery, L. D. K., Bourne, S., Xynos, J. D., Wood, H. B., Hughes, F. J., Hughes, S. P. F., Episkopou, V., & Polak, J. M. (2001) · Tissue Engineering · doi:10.1089/107632700300003323 · Cited by 391 · see citing works

Glucocorticoids suppress bone formation via the osteoclast.

Kim, H.-J. (2006) · Journal of Clinical Investigation · doi:10.1172/jci28084 · Cited by 384 · see citing works

Use of oral corticosteroids in the community and the prevention of secondary osteoporosis: a cross sectional study

Walsh, L. J., Wong, C. A., Pringle, M., & Tattersfield, A. E. (1996) · BMJ · doi:10.1136/bmj.313.7053.344 · Cited by 383 · see citing works

Penetration of Dexamethasone into Brain Glucocorticoid Targets Is Enhanced in mdr1A P-Glycoprotein Knockout Mice

Meijer, O. C., de Lange, E. C. M., Breimer, D. D., de Boer, A. G., Workel, J. O., & de Kloet, E. R. (1998) · Endocrinology · doi:10.1210/endo.139.4.5917 · Cited by 376 · see citing works

The Multifaceted Mineralocorticoid Receptor

Gómez-Sánchez, E. P., & Gómez-Sánchez, C. E. (2014) · Comprehensive physiology · doi:10.1002/cphy.c130044 · Cited by 373 · see citing works

Bone loss in inflammatory disorders

Hardy, R., & Cooper, M. S. (2009) · Journal of Endocrinology · doi:10.1677/joe-08-0568 · Cited by 365 · see citing works

Glucocorticoid-treated mice have localized changes in trabecular bone material properties and osteocyte lacunar size that are not observed in placebo-treated or estrogen-deficient mice

Lane, N. E., Yao, W., Balooch, M., Nalla, R. K., Balooch, G., Habelitz, S., Kinney, J. H., & Bonewald, L. F. (2006) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.051103 · Cited by 355 · see citing works

Dexamethasone induction of osteoblast mRNAs in rat marrow stromal cell cultures

Leboy, P. S., Beresford, J. N., Devlin, C., & Owen, M. E. (1991) · Journal of Cellular Physiology · doi:10.1002/jcp.1041460306 · Cited by 343 · see citing works

Defining conditions where long-term glucocorticoid treatment has an acceptably low level of harm to facilitate implementation of existing recommendations: viewpoints from an EULAR task force

Strehl, C., Bijlsma, J. W. J., de Wit, M. P. T., Boers, M., Caeyers, N., Cutolo, M., Dasgupta, B., Dixon, W. G., Geenen, R., Huizinga, T. W. J., et al. (2016) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2015-208916 · Cited by 342 · see citing works

A framework for the development of guidelines for the management of glucocorticoid-induced osteoporosis

Joint IOF-ECTS GIO Guidelines Working Group, Lekamwasam, S., Adachi, J. D., Agnusdei, D., Bilezikian, J. P., Boonen, S., Borgström, F., Cooper, C. C., Díez‐Pérez, A., Eastell, R., et al. (2012) · Osteoporosis International · doi:10.1007/s00198-012-1958-1 · Cited by 335 · see citing works

Separating Transrepression and Transactivation: A Distressing Divorce for the Glucocorticoid Receptor?

Newton, R. C., & Holden, N. S. (2007) · Molecular Pharmacology · doi:10.1124/mol.107.038794 · Cited by 325 · see citing works

Osteocytes, not Osteoblasts or Lining Cells, are the Main Source of the RANKL Required for Osteoclast Formation in Remodeling Bone

Xiong, J., Piemontese, M., Onal, M., Campbell, J., Goellner, J. J., Dusevich, V., Bonewald, L., Manolagas, S. C., & O’Brien, C. A. (2015) · PLOS ONE · doi:10.1371/journal.pone.0138189 · Cited by 323 · see citing works

Guidance for the adjustment of FRAX according to the dose of glucocorticoids

Kanis, J. A., Johansson, H., Odén, A., & McCloskey, E. V. (2011) · Osteoporosis International · doi:10.1007/s00198-010-1524-7 · Cited by 322 · see citing works

Prevalence of long-term oral glucocorticoid prescriptions in the UK over the past 20 years

Fardet, L., Petersen, I., & Nazareth, I. (2011) · Rheumatology · doi:10.1093/rheumatology/ker017 · Cited by 319 · see citing works

Vertebral Fractures: Clinical Importance and Management

Kendler, D. L., Bauer, D. C., Davison, K. S., Dian, L., Hanley, D. A., Harris, S. T., McClung, M. R., Miller, P. D., Schousboe, J. T., Yuen, C. K., et al. (2015) · The American Journal of Medicine · doi:10.1016/j.amjmed.2015.09.020 · Cited by 318 · see citing works

Apoptosis of Osteocytes in Glucocorticoid-Induced Osteonecrosis of the Hip

Weinstein, R. S. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.85.8.2907 · Cited by 315 · see citing works

Physiological Concentrations of Glucocorticoids Stimulate Formation of Bone Nodules from Isolated Rat Calvaria Cells<i>in Vitro</i>

BELLOWS, C. G., AUBIN, J. E., & HEERSCHE, J. N. M. (1987) · Endocrinology · doi:10.1210/endo-121-6-1985 · Cited by 306 · see citing works

Fracture risk with intermittent high‐dose oral glucocorticoid therapy

de Vries, F., Bracke, M., Leufkens, H. G. M., Lammers, J. J., Cooper, C. C., & van Staa, T. P. (2006) · Arthritis & Rheumatism · doi:10.1002/art.22294 · Cited by 297 · see citing works

Effect of glucocorticoid administration on the rate of muscle protein breakdown in vivo in rats, as measured by urinary excretion of Nτ-methylhistidine

Tomas, F. M., Munro, H. N., & Young, V. R. (1979) · Biochemical Journal · doi:10.1042/bj1780139 · Cited by 293 · see citing works

Endogenous glucocorticoids decrease skeletal angiogenesis, vascularity, hydration, and strength in aged mice

Weinstein, R. S., Wan, C., Liu, Q., Wang, Y., Almeida, M., O’Brien, C. A., Thostenson, J., Roberson, P. K., Boskey, A. L., Clemens, T. L., et al. (2009) · Aging Cell · doi:10.1111/j.1474-9726.2009.00545.x · Cited by 276 · see citing works

11β-HSD1 is the major regulator of the tissue-specific effects of circulating glucocorticoid excess

Morgan, S., McCabe, E. L., Gathercole, L., Hassan-Smith, Z. K., Larner, D. P., Bujalska, I. J., Stewart, P. M., Tomlinson, J., & Lavery, G. G. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1323681111 · Cited by 273 · see citing works

Glucocorticoids and Tumor Necrosis Factor α Increase Oxidative Stress and Suppress Wnt Protein Signaling in Osteoblasts

Almeida, M., Li, H., Ambrogini, E., Weinstein, R. S., & Manolagas, S. C. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.283481 · Cited by 271 · see citing works

Glucocorticoid suppresses the canonical Wnt signal in cultured human osteoblasts

Ohnaka, K., Tanabe, M., Kawate, H., Nawata, H., & Takayanagi, R. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.01.117 · Cited by 270 · see citing works

A polymorphism in the glucocorticoid receptor gene may be associated with an increased sensitivity to glucocorticoids in vivo

Huizenga, N. A. T. M. (1998) · Journal of Clinical Endocrinology &amp; Metabolism · doi:10.1210/jc.83.1.144 · Cited by 265 · see citing works

Muscle strength as a predictor of bone mineral density in young women

Snow-Harter, C., Bouxsein, M., Lewis, B., Charette, S. L., Weinstein, P., & Marcus, R. (1990) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650050608 · Cited by 263 · see citing works

A bispecific antibody targeting sclerostin and DKK-1 promotes bone mass accrual and fracture repair

Florio, M., Gunasekaran, K., Stolina, M., Li, X., Liu, L., Tipton, B., Salimi-Moosavi, H., Asuncion, F., Li, C., Sun, B., et al. (2016) · Nature Communications · doi:10.1038/ncomms11505 · Cited by 258 · see citing works

Clinical Features Associated with Glucocorticoid Receptor Polymorphisms: An Overview

Manenschijn, L., van den Akker, E. L. T., Lamberts, S. W. J., & van Rossum, E. F. C. (2009) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2009.05013.x · Cited by 249 · see citing works

Risk of Atypical Femoral Fracture during and after Bisphosphonate Use

Schilcher, J., Koeppen, V., Aspenberg, P., & Michaëlsson, K. (2014) · New England Journal of Medicine · doi:10.1056/nejmc1403799 · Cited by 247 · see citing works

11β-Hydroxysteroid dehydrogenases and the brain: From zero to hero, a decade of progress

Wyrwoll, C. S., Holmes, M. C., & Seckl, J. R. (2011) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2010.12.001 · Cited by 244 · see citing works

Type 2 diabetes and the skeleton: new insights into sweet bones

Shanbhogue, V. V., Mitchell, D. M., Rosen, C. J., & Bouxsein, M. (2015) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(15)00283-1 · Cited by 237 · see citing works

Randomized Placebo-Controlled Trial of Androgen Effects on Muscle and Bone in Men Requiring Long-Term Systemic Glucocorticoid Treatment

Crawford, B. A. L., Liu, P. Y., Kean, M. T., Bleasel, J. F., & Handelsman, D. J. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-021827 · Cited by 235 · see citing works

Effect of hormone replacement therapy on bone mass in rheumatoid arthritis patients treated with and without steroids

Hall, G. M., Daniels, M., Doyle, D., & Spector, T. D. (1994) · Arthritis & Rheumatism · doi:10.1002/art.1780371014 · Cited by 228 · see citing works

Modulation of 11β-Hydroxysteroid Dehydrogenase Isozymes by Proinflammatory Cytokines in Osteoblasts: An Autocrine Switch from Glucocorticoid Inactivation to Activation

Cooper, M. S., Bujalska, I. J., Rabbitt, E. H., Walker, E. A., Bland, R., Sheppard, M. C., Hewison, M., & Stewart, P. M. (2001) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2001.16.6.1037 · Cited by 227 · see citing works

Glucocorticoid treatment and endocrine pancreas function: implications for glucose homeostasis, insulin resistance and diabetes

Rafacho, A., Ortsäter, H., Nadal, A., & Quesada, I. (2014) · Journal of Endocrinology · doi:10.1530/joe-14-0373 · Cited by 216 · see citing works

The Impact of Diabetes and Diabetes Medications on Bone Health

Gilbert, M. P., & Pratley, R. E. (2015) · Endocrine Reviews · doi:10.1210/er.2012-1042 · Cited by 210 · see citing works

Effect of Glucocorticoids on Function of the Parathyroid Glands in Man

FUCIK, R. F., Kukreja, S. C., HARGIS, G. K., Bowser, E. N., HENDERSON, W. J., & WILLIAMS, G. A. (1975) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-40-1-152 · Cited by 210 · see citing works

Denosumab versus risedronate in glucocorticoid-induced osteoporosis: a multicentre, randomised, double-blind, active-controlled, double-dummy, non-inferiority study

Saag, K. G., Wagman, R. B., Geusens, P., Adachi, J. D., Messina, O. D., Emkey, R. D., Chapurlat, R. D., Wang, A., Pannacciulli, N., & Lems, W. F. (2018) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(18)30075-5 · Cited by 210 · see citing works

Hexose-6-phosphate dehydrogenase knock-out mice lack 11β-hydroxysteroid dehydrogenase type 1-mediated glucocorticoid generation

Lavery, G. G., Walker, E. A., Draper, N., Jeyasuria, P., Marcos, J., Shackleton, C. H. L., Parker, K. L., White, P. C., & Stewart, P. M. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m512635200 · Cited by 207 · see citing works

Alendronate or Alfacalcidol in Glucocorticoid-Induced Osteoporosis

de Nijs, R. N. J., Jacobs, J. W. G., Lems, W. F., Laan, R., Algra, A., Huisman, A.-M., Buskens, E., Laet, C. E. D. H. D., Oostveen, A. C. M., Geusens, P., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa053569 · Cited by 207 · see citing works

Cortisol inhibits the synthesis of insulin-like growth factor-I in skeletal cells.

MCCARTHY, T. L., CENTRELLA, M., & CANALIS, E. (1990) · Endocrinology · doi:10.1210/endo-126-3-1569 · Cited by 204 · see citing works

Risk of atypical femoral fracture during and after bisphosphonate use

Schilcher, J., Koeppen, V., Aspenberg, P., & Michaëlsson, K. (2015) · Acta Orthopaedica · doi:10.3109/17453674.2015.1004149 · Cited by 202 · see citing works

Osteoblastic 11β-hydroxysteroid dehydrogenase type 1 activity increases with age and glucocorticoid exposure

Cooper, M. S., Rabbitt, E. H., Goddard, P. E., Bartlett, W. A., Hewison, M., & Stewart, P. M. (2002) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2002.17.6.979 · Cited by 200 · see citing works

Glucocorticoid enhances the expression of dickkopf-1 in human osteoblasts: novel mechanism of glucocorticoid-induced osteoporosis

Ohnaka, K., Taniguchi, H., Kawate, H., Nawata, H., & Takayanagi, R. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.04.025 · Cited by 198 · see citing works

11β-hydroxysteroid dehydrogenase 1: translational and therapeutic aspects

Gathercole, L. L., Lavery, G. G., Morgan, S. A., Cooper, M. S., Sinclair, A. J., Tomlinson, J. W., & Stewart, P. M. (2013) · Endocrine Reviews · doi:10.1210/er.2012-1050 · Cited by 196 · see citing works

Glucocorticoid induced autophagy in osteocytes

Xia, X., Kar, R., Gluhak-Heinrich, J., Yao, W., Lane, N. E., Bonewald, L. F., Biswas, S. K., Lo, W.-K., & Jiang, J. X. (2010) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.160 · Cited by 193 · see citing works

The Role of Parathyroid Hormone in the Pathogenesis of Glucocorticoid-Induced Osteoporosis: A Re-Examination of the Evidence

Rubin, M. R., & Bilezikian, J. P. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-012101 · Cited by 191 · see citing works

Osteoblasts mediate the adverse effects of glucocorticoids on fuel metabolism

Brennan‐Speranza, T. C., Henneicke, H., Gasparini, S. J., Blankenstein, K. I., Heinevetter, U., Cogger, V. C., Svistounov, D., Zhang, Y., Cooney, G. J., Buttgereit, F., et al. (2012) · Journal of Clinical Investigation · doi:10.1172/jci63377 · Cited by 187 · see citing works

Osteoprotegerin mRNA is expressed in primary human osteoblast-like cells: down-regulation by glucocorticoids.

Vidal, N., Brandstrom, H., Jonsson, K., & Ohlsson, C. (1998) · Journal of Endocrinology · doi:10.1677/joe.0.1590191 · Cited by 185 · see citing works

Inflammatory diseases and bone fragility

Briot, K., Geusens, P., Bultink, I., Lems, W., & Roux, C. (2017) · Osteoporosis International · doi:10.1007/s00198-017-4189-7 · Cited by 182 · see citing works

Bone mineral density and bone turnover before and after surgical cure of Cushing's syndrome.

Hermus, A., Smals, A., Swinkels, L., Huysmans, D., Pieters, G., Sweep, C., Corstens, F., & Kloppenborg, P. (1995) · Journal of Clinical Endocrinology and Metabolism · doi:10.1210/jcem.80.10.7559865 · Cited by 181 · see citing works

Glucocorticoids inhibit bone resorption by isolated rat osteoclasts by enhancing apoptosis

Dempster, D., Moonga, B., Stein, L., Horbert, W., & Antakly, T. (1997) · Journal of Endocrinology · doi:10.1677/joe.0.1540397 · Cited by 180 · see citing works

Osteoclastic activation is the principal mechanism leading to secondary osteoporosis in rheumatoid arthritis.

Gough, A., Sambrook, P. N., Devlin, J., Huissoon, A. P., Njeh, C. F., Robbins, S., Nguyen, T. D., & Emery, P. (1998) · PubMed · Cited by 178 · see citing works

Comparative effects of teriparatide and risedronate in glucocorticoid-induced osteoporosis in men: 18-month results of the EuroGIOPs trial

Glüer, C.-C., Marin, F., Ringe, J. D., Hawkins, F., Möricke, R., Papaioannu, N., Farahmand, P., Minisola, S., Martínez, G., Nolla, J. M., et al. (2013) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.1870 · Cited by 171 · see citing works

Bone mineral density, prevalence of vertebral fractures, and bone quality in patients with adrenal incidentalomas with and without subclinical hypercortisolism: an Italian multicenter study

Chiodini, I., Morelli, V., Masserini, B., Salcuni, A. S., Eller-Vainicher, C., Viti, R., Coletti, F., Guglielmi, G., Battista, C., Carnevale, V., et al. (2009) · The Journal of Clinical Endocrinology &amp; Metabolism · doi:10.1210/jc.2009-0468 · Cited by 168 · see citing works

Glucocorticoid regulation of transforming growth factor beta 1 activity and binding in osteoblast-enriched cultures from fetal rat bone.

Centrella, M., McCarthy, T. L., & CANALIS, E. M. (1991) · Molecular and Cellular Biology · doi:10.1128/mcb.11.9.4490 · Cited by 164 · see citing works

Bone demineralization and vertebral fractures in endogenous cortisol excess: role of disease etiology and gonadal status.

Tauchmanovà, L., Pivonello, R., Somma, C. D., Rossi, R., Martino, M. D. D., Camera, L., Klain, M., Salvatore, M., Lombardi, G., & Colao, A. (2006) · Journal of Clinical Endocrinology and Metabolism · doi:10.1210/jc.2005-0582 · Cited by 162 · see citing works

Profiles of Endogenous Circulating Cortisol and Bone Mineral Density in Healthy Elderly Men1

Dennison, E. M., Hindmarsh, P. C., Fall, C. H. D., Kellingray, S., Barker, D. J. P., Phillips, D. I., & Cooper, C. C. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.84.9.5964 · Cited by 162 · see citing works

Subclinical hypercortisolism among outpatients referred for osteoporosis.

Chiodini, I., Mascia, M. L., Muscarella, S., Battista, C., Minisola, S., Arosio, M., Santini, S. A., Guglielmi, G., Carnevale, V., & Scillitani, A. (2007) · Annals of Internal Medicine · doi:10.7326/0003-4819-147-8-200710160-00006 · Cited by 162 · see citing works

Atypical Femoral Fractures and Bisphosphonate Use

Girgis, C. M., Sher, D., & Seibel, M. J. (2010) · New England Journal of Medicine · doi:10.1056/nejmc0910389 · Cited by 161 · see citing works

Osteoblasts Directly Control Lineage Commitment of Mesenchymal Progenitor Cells through Wnt Signaling

Zhou, H., Mak, W., Zheng, Y., Dunstan, C. R., & Seibel, M. J. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m702687200 · Cited by 159 · see citing works

Glucocorticoid dose determines osteocyte cell fate

Jia, J., Yao, W., Guan, M., Dai, W., Shahnazari, M., Kar, R., Bonewald, L., Jiang, J. X., & Lane, N. E. (2011) · The FASEB Journal · doi:10.1096/fj.11-182519 · Cited by 157 · see citing works

Expression and functional consequences of 11β-hydroxysteroid dehydrogenase activity in human bone

Cooper, M. S., Walker, E. A., Bland, R., Fraser, W. D., Hewison, M., & Stewart, P. M. (2000) · Bone · doi:10.1016/s8756-3282(00)00344-6 · Cited by 154 · see citing works

Alterations of Bone Turnover and Bone Mass at Different Skeletal Sites due to Pure Glucocorticoid Excess: Study in Eumenorrheic Patients with Cushing's Syndrome

Chiodini, I., Carnevale, V., Torlontano, M., Fusilli, S., Guglielmi, G., Pileri, M., Modoni, S., Giorgio, A. D., Liuzzi, A., Minisola, S., et al. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.83.6.4880 · Cited by 154 · see citing works

Functional outcome and quality of life in adult patients with idiopathic inflammatory myositis

Ponyi, A. (2004) · British journal of rheumatology · doi:10.1093/rheumatology/keh404 · Cited by 154 · see citing works

Fractures and bone mineral density in adult women with 21-hydroxylase deficiency

Falhammar, H., Filipsson, H., Holmdahl, G., Janson, P.-O., Nordenskjöld, A., Hagenfeldt, K., & Thorén, M. (2007) · The Journal of Clinical Endocrinology &amp; Metabolism · doi:10.1210/jc.2007-0744 · Cited by 151 · see citing works

Glucocorticoid-Induced Osteoporosis

Frenkel, B., White, W., & Tuckermann, J. P. (2015) · Advances in experimental medicine and biology · doi:10.1007/978-1-4939-2895-8_8 · Cited by 148 · see citing works

Fracture risk in oral glucocorticoid users: a Bayesian meta-regression leveraging control arms of osteoporosis clinical trials

Amiche, M. A., Albaum, J. M., Tadrous, M., Pechlivanoglou, P., Lévesque, L. E., Adachi, J. D., & Cadarette, S. M. (2015) · Osteoporosis International · doi:10.1007/s00198-015-3455-9 · Cited by 144 · see citing works

Normal bone mineral density following cure of Cushing's syndrome

Manning, P. J., Evans, M. C., & Reid, I. R. (1992) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1992.tb01437.x · Cited by 143 · see citing works

Bone quality, as measured by trabecular bone score in patients with adrenal incidentalomas with and without subclinical hypercortisolism

Eller-Vainicher, C., Morelli, V., Ulivieri, F. M., Palmieri, S., Zhukouskaya, V. V., Cairoli, E., Pino, R., Naccarato, A., Scillitani, A., Beck-Peccoz, P., et al. (2012) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.1648 · Cited by 143 · see citing works

Effects of high doses of glucocorticoids on free amino acids, ribosomes and protein turnover in human muscle

Löfberg, E., Gutiérrez, A., Wernerman, J., Anderstam, B., Mitch, W. E., Price, S. R., Bergström, J. P., & Alvestrand, A. (2002) · European Journal of Clinical Investigation · doi:10.1046/j.1365-2362.2002.00993.x · Cited by 142 · see citing works

Bone Mineral Density Is Not Significantly Reduced in Adult Patients on Low-Dose Glucocorticoid Replacement Therapy

Koetz, K., Ventz, M., Diederich, S., & Quinkler, M. O. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-2036 · Cited by 141 · see citing works

Expansion of Bone Marrow Adipose Tissue During Caloric Restriction Is Associated With Increased Circulating Glucocorticoids and Not With Hypoleptinemia

Cawthorn, W. P., Scheller, E. L., Parlee, S. D., Pham, H. A., Learman, B. S., Redshaw, C., Sulston, R. J., Burr, A. A., Das, A. K., Simon, B. R., et al. (2015) · Endocrinology · doi:10.1210/en.2015-1477 · Cited by 141 · see citing works

Glucocorticoids Induce Bone and Muscle Atrophy by Tissue-Specific Mechanisms Upstream of E3 Ubiquitin Ligases

Sato, A. Y., Richardson, D., Cregor, M. D., Davis, H. M., Au, E. D., McAndrews, K., Zimmers, T. A., Organ, J. M., Peacock, M., Plotkin, L. I., et al. (2017) · Endocrinology · doi:10.1210/en.2016-1779 · Cited by 141 · see citing works

Increased risk of osteoporotic fractures in patients with Cushing's syndrome

Vestergaard, P. F., Lindholm, J., Jørgensen, J. O. L., Hagen, C., Hoeck, H. C., Laurberg, P. T., Rejnmark, L., Brixen, K., Kristensen, L., Feldt‐Rasmussen, U., et al. (2002) · European Journal of Endocrinology · doi:10.1530/eje.0.1460051 · Cited by 137 · see citing works

Protection From Glucocorticoid-Induced Osteoporosis by Anti-Catabolic Signaling in the Absence of Sost/Sclerostin

Sato, A. Y., Cregor, M. D., Delgado‐Calle, J., Condon, K. W., Allen, M. R., Peacock, M., Plotkin, L. I., & Bellido, T. (2016) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.2869 · Cited by 134 · see citing works

Glucocorticoids Induce Osteocyte Apoptosis by Blocking Focal Adhesion Kinase-mediated Survival

Plotkin, L. I., Manolagas, S. C., & Bellido, T. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m611435200 · Cited by 132 · see citing works

Evolutionary medicine and bone loss in chronic inflammatory diseases—A theory of inflammation-related osteopenia

Straub, R. H., Cutolo, M., & Pacifici, R. (2015) · Seminars in Arthritis and Rheumatism · doi:10.1016/j.semarthrit.2015.04.014 · Cited by 132 · see citing works

Expression of Type 2 11β-Hydroxysteroid Dehydrogenase and Corticosteroid Hormone Receptors in Early Human Fetal Life1

Condon, J. C., Gosden, C. M., Gardener, D., Nickson, P., Hewison, M., Howie, A. J., & Stewart, P. M. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.83.12.5302 · Cited by 125 · see citing works

Influence of Glucocorticoids on Human Osteoclast Generation and Activity

Sivagurunathan, S., Muir, M. M., Brennan‐Speranza, T. C., Seale, J. P., & Mason, R. S. (2005) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.041233 · Cited by 125 · see citing works

Transgenic Expression of 11β-Hydroxysteroid Dehydrogenase Type 2 in Osteoblasts Reveals an Anabolic Role for Endogenous Glucocorticoids in Bone

Sher, L. B., Woitge, H. W., Adams, D. J., Gronowicz, G., Krozowski, Z. S., Harrison, J. R., & Kream, B. E. (2003) · Endocrinology · doi:10.1210/en.2003-0655 · Cited by 124 · see citing works

Inactivation of autophagy ameliorates glucocorticoid-induced and ovariectomy-induced bone loss

Lin, N.-Y., Chen, C.-W., Kagwiria, R., Liang, R., Beyer, C., Distler, A., Luther, J., Engelke, K., Schett, G., & Distler, J. H. (2016) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2015-207240 · Cited by 123 · see citing works

Anti-inflammatory drugs suppress proliferation and induce apoptosis through altering expressions of cell cycle regulators and pro-apoptotic factors in cultured human osteoblasts

Chang, J., Li, C.-J., Liao, H.-J., Wang, C., Wang, G., & Ho, M. (2009) · Toxicology · doi:10.1016/j.tox.2009.01.016 · Cited by 120 · see citing works

Prophylactic Use of Alfacalcidol in Corticosteroid-Induced Osteoporosis

Reginster, J., Kuntz, D., Verdickt, W., Wouters, M., Guillevin, L., Menkes, C. J., & Nielsen, K. G. (1999) · Osteoporosis International · doi:10.1007/s001980050118 · Cited by 120 · see citing works

Cortical bone loss caused by glucocorticoid excess requires RANKL production by osteocytes and is associated with reduced OPG expression in mice

Piemontese, M., Xiong, J., Fujiwara, Y., Thostenson, J. D., & O’Brien, C. A. (2016) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00219.2016 · Cited by 118 · see citing works

Glucocorticoid Receptor and Sequential P53 Activation by Dexamethasone Mediates Apoptosis and Cell Cycle Arrest of Osteoblastic MC3T3-E1 Cells

Li, H., Qian, W., Weng, X., Wu, Z.-H., Li, H.-H., Zhuang, Q., Feng, B., & Bian, Y. (2012) · PLoS ONE · doi:10.1371/journal.pone.0037030 · Cited by 117 · see citing works

Sclerostin-antibody treatment of glucocorticoid-induced osteoporosis maintained bone mass and strength

Yao, W., Dai, W., Jiang, L., Lay, E. Y.-A., Zhong, Z. A., Ritchie, R. O., Li, X., Ke, H. Z., & Lane, N. E. (2015) · Osteoporosis International · doi:10.1007/s00198-015-3308-6 · Cited by 116 · see citing works

Evidence for Osteocalcin Binding and Activation of GPRC6A in β-Cells

Pi, M., Kapoor, K., Ye, R.-S., Nishimoto, S. K., Smith, J. C., Baudry, J. Y., & Quarles, L. D. (2016) · Endocrinology · doi:10.1210/en.2015-2010 · Cited by 116 · see citing works

Intermittent Parathyroid Hormone Administration Counteracts the Adverse Effects of Glucocorticoids on Osteoblast and Osteocyte Viability, Bone Formation, and Strength in Mice

Weinstein, R. S., Jilka, R. L., Almeida, M., Roberson, P. K., & Manolagas, S. C. (2010) · Endocrinology · doi:10.1210/en.2009-1488 · Cited by 115 · see citing works

Regional Trabecular Bone Matrix Degeneration and Osteocyte Death in Femora of Glucocorticoid- Treated Rabbits

Eberhardt, A. W., Yeager-Jones, A., & Blair, H. C. (2001) · Endocrinology · doi:10.1210/endo.142.3.8048 · Cited by 115 · see citing works

The Impact of Oral Corticosteroid Use on Bone Mineral Density and Vertebral Fracture

Walsh, L. J., Lewis, S., Wong, C., Cooper, S., Oborne, J., Cawte, S. A., Harrison, T., Green, D. J., Pringle, M., Hubbard, R., et al. (2002) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.2110047 · Cited by 115 · see citing works

Glucocorticoid Regulation of Osteoclast Differentiation and Expression of Receptor Activator of Nuclear Factor-κB (NF-κB) Ligand, Osteoprotegerin, and Receptor Activator of NF-κB in Mouse Calvarial Bones

Swanson, C., Lorentzon, M., Conaway, H. H., & Lerner, U. H. (2006) · Endocrinology · doi:10.1210/en.2005-0717 · Cited by 114 · see citing works

Regulation of Osteoprotegerin Secretion from Primary Cultures of Human Bone Marrow Stromal Cells

Brändström, H., Björkman, T., & Ljunggren, Ö. (2001) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2000.4223 · Cited by 113 · see citing works

Elevated Salivary Cortisol in the Evening in Healthy Elderly Men and Women: Correlation With Bone Mineral Density

Raff, H., Raff, J. L., Duthie, E. H., Wilson, C. R., Sasse, E. A., Rudman, I. W., & Mattson, D. L. (1999) · The Journals of Gerontology Series A · doi:10.1093/gerona/54.9.m479 · Cited by 108 · see citing works

Developmentally regulated expression of adrenal 17 alpha-hydroxylase cytochrome P450 in the mouse embryo

Keeney, D. S., Jenkins, C. M., & Waterman, M. R. (1995) · Endocrinology · doi:10.1210/endo.136.11.7588219 · Cited by 108 · see citing works

The impact of glucocorticoid therapy on trabecular bone score in older women

Paggiosi, M., Peel, N. F. A., & Eastell, R. (2015) · Osteoporosis International · doi:10.1007/s00198-015-3078-1 · Cited by 105 · see citing works

Colocalization of Glucocorticoid and Mineralocorticoid Receptors in Human Bone

Beavan, S. R., Horner, A. A., Bord, S., Ireland, D., & Compston, J. E. (2001) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2001.16.8.1496 · Cited by 104 · see citing works

Comparative Analysis of the Radiology of Osteoporotic Vertebral Fractures in Women and Men: Cross-Sectional and Longitudinal Observations from the Canadian Multicentre Osteoporosis Study (CaMos)

Lentle, B. C., Berger, C., Probyn, L. J., Brown, J. P., Langsetmo, L., Fine, B., Lian, K., Shergill, A. K., Trollip, J., Jackson, S., et al. (2017) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.3222 · Cited by 104 · see citing works

Glucocorticoid exposure and fracture risk in patients with new-onset rheumatoid arthritis

Balasubramanian, A., Wade, S. W., Adler, R. A., Lin, C. J. F., Maricic, M. J., O’Malley, C. D., Saag, K. G., & Curtis, J. R. (2016) · Osteoporosis International · doi:10.1007/s00198-016-3646-z · Cited by 101 · see citing works

Glucocorticoid-dependent Wnt signaling by mature osteoblasts is a key regulator of cranial skeletal development in mice

Zhou, H., Mak, W., Kalak, R., Street, J. A., Fong-Yee, C., Zheng, Y., Dunstan, C. R., & Seibel, M. J. (2009) · Development · doi:10.1242/dev.027706 · Cited by 99 · see citing works

Effect of corticosteroids on human osteoclast formation and activity

HIRAYAMA, T., Sabokbar, A., & Athanasou, N. A. (2002) · Journal of Endocrinology · doi:10.1677/joe.0.1750155 · Cited by 99 · see citing works

Vhl deletion in osteoblasts boosts cellular glycolysis and improves global glucose metabolism

Dirckx, N., Tower, R. J., Mercken, E. M., Vangoitsenhoven, R., Moreau-Triby, C., Breugelmans, T., Nefyodova, E., Cardoen, R., Mathieu, C., der Schueren, B. V., et al. (2018) · Journal of Clinical Investigation · doi:10.1172/jci97794 · Cited by 99 · see citing works

Characterization of Insulin-Like Growth Factor I Receptors on Cultured Rat Bone Cells: Regulation of Receptor Concentration by Glucocorticoids*

Bennett, A. E., Chen, T. L., Feldman, D., Hintz, R. L., & Rosenfeld, R. G. (1984) · Endocrinology · doi:10.1210/endo-115-4-1577 · Cited by 98 · see citing works

11β-Hydroxysteroid Dehydrogenase Type 1 Activity Predicts the Effects of Glucocorticoids on Bone

Cooper, M. S., Blumsohn, A., Goddard, P. E., Bartlett, W. A., Shackleton, C. H. L., Eastell, R., Hewison, M., & Stewart, P. M. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-022025 · Cited by 97 · see citing works

Insulin-Like Growth Factor-I Gene Transfer by Electroporation Prevents Skeletal Muscle Atrophy in Glucocorticoid-Treated Rats

Schakman, O., Gilson, H., de Coninck, V., Lause, P., Verniers, J., Havaux, X., Ketelslegers, J., & Thissen, J. (2005) · Endocrinology · doi:10.1210/en.2004-1594 · Cited by 95 · see citing works

11β-Hydroxysteroid Dehydrogenase Expression and Glucocorticoid Synthesis Are Directed by a Molecular Switch during Osteoblast Differentiation

Eijken, M., Hewison, M., Cooper, M. S., de Jong, F. H., Chiba, H., Stewart, P. M., Uitterlinden, A. G., Pols, H. A. P., & van Leeuwen, J. P. T. M. (2004) · Molecular Endocrinology · doi:10.1210/me.2004-0212 · Cited by 94 · see citing works

Higher Serum Undercarboxylated Osteocalcin and Other Bone Turnover Markers Are Associated With Reduced Diabetes Risk and Lower Estradiol Concentrations in Older Men

Yeap, B. B., Alfonso, H. S., Chubb, S. A. P., Gauci, R., Byrnes, E., Beilby, J. P., Ebeling, P. R., Handelsman, D. J., Allan, C. A., Grossmann, M., et al. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-3019 · Cited by 94 · see citing works

Effects of the Circadian Variation in Serum Cortisol on Markers of Bone Turnover and Calcium Homeostasis in Normal Postmenopausal Women1

Heshmati, H. M., Riggs, B. L., Burritt, M. F., McAlister, C. A., Wollan, P. C., & Khosla, S. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.83.3.4627 · Cited by 92 · see citing works

Glucocorticoids: Dose-related effects on osteoclast formation and function via reactive oxygen species and autophagy

Shi, J., Wang, L., Zhang, H., Jie, Q., Li, X., Shi, Q., Huang, Q., Gao, B., Han, Y., Guo, K. X., et al. (2015) · Bone · doi:10.1016/j.bone.2015.06.014 · Cited by 90 · see citing works

Trabecular Bone Score in Patients With Chronic Glucocorticoid Therapy–Induced Osteoporosis Treated With Alendronate or Teriparatide

Saag, K. G., Agnusdei, D., Hans, D. B., Kohlmeier, L., Krohn, K., Leib, E. S., Maclaughlin, E. J., Alam, J., Simonelli, C., Taylor, K. A., et al. (2016) · Arthritis & Rheumatology · doi:10.1002/art.39726 · Cited by 90 · see citing works

Biphasic Glucocorticoid-Dependent Regulation of Wnt Expression and Its Inhibitors in Mature Osteoblastic Cells

Mak, W., Shao, X., Dunstan, C. R., Seibel, M. J., & Zhou, H. (2009) · Calcified Tissue International · doi:10.1007/s00223-009-9303-1 · Cited by 89 · see citing works

Bone mineral density

Marquezan, M., Lau, T. C. L., Mattos, C. T., et al. (2011) · The Angle Orthodontist · doi:10.2319/031811-192.1 · Cited by 89 · see citing works

A chimeric antibody with the human ?1 constant region as a putative standard for assays to detect IgG ?2-glycoprotein I-dependent anticardiolipin and anti-?2-glycoprotein I antibodies

Ichikawa, K., Tsutsumi, A., Atsumi, T., Matsuura, E., Kobayashi, S., Hughes, G. R. V., Khamashta, M. A., & Koike, T. (1999) · Arthritis & Rheumatism · doi:10.1002/1529-0131(199911)42:11 · Cited by 88 · see citing works

Prereceptor regulation of glucocorticoid action by 11β‐hydroxysteroid dehydrogenase: a novel determinant of cell proliferation

Rabbitt, E. H., Lavery, G. G., Walker, E. A., Cooper, M. S., Stewart, P. M., & Hewison, M. (2002) · The FASEB Journal · doi:10.1096/fj.01-0582com · Cited by 88 · see citing works

Expression of dentin matrix protein 1 (DMP1) in nonmineralized tissues

Terasawa, M., Shimokawa, R., Terashima, T., Ohya, K., Takagi, Y., & Shimokawa, H. (2004) · Journal of Bone and Mineral Metabolism · doi:10.1007/s00774-004-0504-4 · Cited by 88 · see citing works

Mesenchymal progenitors in osteopenias of diverse pathologies: differential characteristics in the common shift from osteoblastogenesis to adipogenesis

Sui, B., Hu, C., Liao, L., Chen, Y., Zhang, X., Fu, X., Zheng, C., Li, M., Wu, L., Zhao, X., et al. (2016) · Scientific Reports · doi:10.1038/srep30186 · Cited by 88 · see citing works

Switching of oral bisphosphonates to denosumab in chronic glucocorticoid users: A 12-month randomized controlled trial

Mok, C. C., Ho, L. Y., & Ma, K. M. (2015) · Bone · doi:10.1016/j.bone.2015.03.002 · Cited by 87 · see citing works

Selective glucocorticoid receptor modulation maintains bone mineral density in mice

Thiele, S., Ziegler, N., Tsourdi, E. A., Bosscher, K. D., Tuckermann, J. P., Hofbauer, L. C., & Rauner, M. (2012) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.1688 · Cited by 85 · see citing works

Anabolic Bone Formation Via a Site-Specific Bone-Targeting Delivery System by Interfering With Semaphorin 4d Expression

Zhang, Y., Wei, L., Miron, R. J., Shi, B., & Bian, Z. (2014) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.2322 · Cited by 85 · see citing works

The role of corticosterone in human hypothalamic– pituitary–adrenal axis feedback

Raubenheimer, P. J., Young, E. A., Andrew, R., & Seckl, J. R. (2006) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2006.02540.x · Cited by 84 · see citing works

Bone Tissue Properties Measurement by Reference Point Indentation in Glucocorticoid-Induced Osteoporosis

Mellibovsky, L., Prieto‐Alhambra, D., Mellibovsky, F., Güerri‐Fernández, R., Nogués, X., Randall, C. J., Hansma, P. K., & Díez‐Pérez, A. (2015) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.2497 · Cited by 84 · see citing works

Risk of hip fracture in Addison’s disease: a population-based cohort study

Björnsdottir, S., Sääf, M., Bensing, S., Kämpe, O., Michaëlsson, K., & Ludvigsson, J. F. (2011) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2011.02352.x · Cited by 82 · see citing works

Bone mineral density, bone markers, and fractures in adult males with congenital adrenal hyperplasia

Falhammar, H., Filipsson Nyström, H., Wedell, A., Brismar, K., & Thorén, M. (2013) · European Journal of Endocrinology · doi:10.1530/eje-12-0865 · Cited by 82 · see citing works

Glucocorticoid‐induced osteoporosis: lessons from <scp>C</scp>ushing's syndrome

Tóth, M., & Grossman, A. (2013) · Clinical Endocrinology · doi:10.1111/cen.12189 · Cited by 81 · see citing works

Glucocorticoid Regulation of the Promoter of 11β-Hydroxysteroid Dehydrogenase Type 1 Is Indirect and Requires CCAAT/Enhancer-Binding Protein-β

Sai, S., Esteves, C. L., Kelly, V., Michailidou, Z., Anderson, K., Coll, A. P., Nakagawa, Y., Ohzeki, T., Seckl, J. R., & Chapman, K. E. (2008) · Molecular Endocrinology · doi:10.1210/me.2007-0489 · Cited by 81 · see citing works

Characterization of 11beta-hydroxysteroid dehydrogenase activity and corticosteroid receptor expression in human osteosarcoma cell lines

Bland, R., Worker, C., Noble, B., Eyre, L. J., Bujalska, I., Mc, S., Stewart, P., & Hewison, M. (1999) · Journal of Endocrinology · doi:10.1677/joe.0.1610455 · Cited by 80 · see citing works

Treatment of Glucocorticoid-Induced Osteoporosis with Alfacalcidol/Calcium Versus Vitamin D/Calcium

Ringe, J. D., Cöster, A., Meng, T., Schacht, E., & Umbach, R. (1999) · Calcified Tissue International · doi:10.1007/s002239900708 · Cited by 79 · see citing works

Risk of diabetes mellitus associated with disease-modifying antirheumatic drugs and statins in rheumatoid arthritis

Özen, G., Pedro, S., Holmqvist, M. E., Avery, M., Wolfe, F., & Michaud, K. D. (2016) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2016-209954 · Cited by 79 · see citing works

Mice Deficient in 11β-Hydroxysteroid Dehydrogenase Type 1 Lack Bone Marrow Adipocytes, but Maintain Normal Bone Formation

Justesen, J., Mosekilde, L., Holmes, M. C., Stenderup, K., Gasser, J. A., Mullins, J. J., Seckl, J. R., & Kassem, M. S. (2004) · Endocrinology · doi:10.1210/en.2003-1427 · Cited by 78 · see citing works

Growth hormone has anabolic effects in glucocorticosteroid-dependent children with inflammatory bowel disease: A pilot study

Mauras, N., George, D. E., Evans, J., Milov, D. E., Abrams, S. A., Rini, A., Welch, S., & Haymond, M. W. (2002) · Metabolism · doi:10.1053/meta.2002.28972 · Cited by 78 · see citing works

The Relation Between Cortisol Excretion and Fractures in Healthy Older People: Results from the MacArthur Studies ‐ Mac

Greendale, G. A., Unger, J. B., Rowe, J. W., & Seeman, T. E. (1999) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.1999.tb03835.x · Cited by 77 · see citing works

Reduction in daily hydrocortisone dose improves bone health in primary adrenal insufficiency

Schulz, J., Frey, K. R., Cooper, M. S., Zopf, K., Ventz, M., Diederich, S., & Quinkler, M. O. (2016) · European Journal of Endocrinology · doi:10.1530/eje-15-1096 · Cited by 77 · see citing works

Polymorphisms in the glucocorticoid receptor gene that modulate glucocorticoid sensitivity are associated with rheumatoid arthritis

van Oosten, M. J. M., Dolhain, R. J. E. M., Koper, J. W., van Rossum, E. F. C., Emonts, M., Han, K. H., Wouters, J. M. G. W., Hazes, J. M., Lamberts, S. W. J., & Feelders, R. A. (2010) · Arthritis Research & Therapy · doi:10.1186/ar3118 · Cited by 76 · see citing works

Endogenous glucocorticoid signalling in osteoblasts is necessary to maintain normal bone structure in mice

Kalak, R., Zhou, H., Street, J. A., Day, R. E., Modzelewski, J. R. K., Spies, C. M., Liu, P. Y., Li, G., Dunstan, C. R., & Seibel, M. J. (2009) · Bone · doi:10.1016/j.bone.2009.03.673 · Cited by 75 · see citing works

The risk factors for fractures and trabecular bone-score value in patients with endogenous Cushing’s syndrome

Belaya, Z. E., Hans, D. B., Rozhinskaya, L. Y., Dragunova, N. V., Sasonova, N. I., Solodovnikov, A. G., Тамерланович, Ц. Т., Dzeranova, L. K., Mel'nichenko, G. A., & Dedov, I. I. (2015) · Archives of Osteoporosis · doi:10.1007/s11657-015-0244-1 · Cited by 74 · see citing works

Adrenalectomy reduces the risk of vertebral fractures in patients with monolateral adrenal incidentalomas and subclinical hypercortisolism

Salcuni, A. S., Morelli, V., Eller-Vainicher, C., Palmieri, S., Cairoli, E., Spada, A., Scillitani, A., & Chiodini, I. (2015) · European Journal of Endocrinology · doi:10.1530/eje-15-0977 · Cited by 74 · see citing works

Mechanisms in endocrinology: endogenous subclinical hypercortisolism and bone: a clinical review

Chiodini, I., Vainicher, C. E., Morelli, V, Palmieri, S., Cairoli, E., Salcuni, A. S., Copetti, M., & Scillitani, A. (2016) · European Journal of Endocrinology · doi:10.1530/eje-16-0289 · Cited by 73 · see citing works

Eugonadal male patients with adrenal incidentalomas and subclinical hypercortisolism have increased rate of vertebral fractures

Chiodini, I., Viti, R., Coletti, F., Guglielmi, G., Battista, C., Ermetici, F., Morelli, V., Salcuni, A. S., Carnevale, V., Urbano, F., et al. (2008) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2008.03310.x · Cited by 71 · see citing works

Corticosteroid Osteoporosis: Practical Implications of Recent Trials

Sambrook, P. N. (2000) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2000.15.9.1645 · Cited by 70 · see citing works

Bone Loss in Rheumatoid Arthritis: Influence of disease activity, duration of the disease, functional capacity, and corticosteroid treatment

Hansen, M. S., Florescu, A., Stoltenberg, M., Pødenphant, J., Pedersen-Zbinden, B., Hørslev-petersen, K., Hyldstrup, L., & Lorenzen, I. (1996) · Scandinavian Journal of Rheumatology · doi:10.3109/03009749609065648 · Cited by 70 · see citing works

Bone loss rate in adrenal incidentalomas: a longitudinal study

Chiodini, I., Torlontano, M., Carnevale, V., Guglielmi, G., Cammisa, M., Trischitta, V., & Scillitani, A. (2001) · The Journal of Clinical Endocrinology &amp; Metabolism · doi:10.1210/jcem.86.11.8022 · Cited by 69 · see citing works

Corticosterone selectively targets endo-cortical surfaces by an osteoblast-dependent mechanism

Henneicke, H., Herrmann, M., Kalak, R., Brennan‐Speranza, T. C., Heinevetter, U., Bertollo, N., Day, R. E., Huscher, D., Buttgereit, F., Dunstan, C. R., et al. (2011) · Bone · doi:10.1016/j.bone.2011.06.013 · Cited by 67 · see citing works

Skeletal differences in bone mineral area and content before and after cure of endogenous Cushing's syndrome

Fütő, L., Tőke, J., Patócs, A., Szappanos, Á., Varga, I., Gláz, E., Tulassay, Z., Rácz, K., & Tóth, M. (2008) · Osteoporosis International · doi:10.1007/s00198-007-0514-x · Cited by 67 · see citing works

Synergistic induction of local glucocorticoid generation by inflammatory cytokines and glucocorticoids: implications for inflammation associated bone loss

Kaur, K., Hardy, R., Ahasan, M. M., Eijken, M., van Leeuwen, J. P. T. M., Filer, A. D., Thomas, A. M. C., Raza, K., Buckley, C. D., Stewart, P. M., et al. (2009) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2009.107466 · Cited by 66 · see citing works

Osteoprogenitor cells in cell populations derived from mouse and rat calvaria differ in their response to corticosterone, cortisol, and cortisone1

Bellows, C. G., Ciaccia, A., & Heersche, J. N. M. (1998) · Bone · doi:10.1016/s8756-3282(98)00084-2 · Cited by 64 · see citing works

Deleterious Effects of Glucocorticoid Replacement on Bone in Women After Long-Term Remission of Cushing's Syndrome

Barahona, M. J., Sucunza, N., Resmini, E., Fernández‐Real, J. M., Ricart, W., Moreno‐Navarrete, J. M., Puig, T., Wägner, A. M., Rodrı́guez-Espinosa, J., Farrerons, J., et al. (2009) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.090505 · Cited by 62 · see citing works

Osteonecrosis of the Hip

Banerjee, S., Issa, K., Pivec, R., et al. (2013) · Orthopedic Clinics of North America · doi:10.1016/j.ocl.2013.07.004 · Cited by 61 · see citing works

Systemic glucocorticoid use in Denmark: a population-based prevalence study

Laugesen, K., Jørgensen, J. O. L., Sørensen, H. T., & Petersen, I. (2017) · BMJ Open · doi:10.1136/bmjopen-2016-015237 · Cited by 61 · see citing works

Human Osteoblast-Like Cells Express Predominantly Steroid 5α-Reductase Type 1

Issa, S., Schnabel, D., Feix, M., Wolf, L., Schaefer, H.-E., Russell, D. W., & Schweikert, H. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2001-011902 · Cited by 59 · see citing works

Regulation of bim in glucocorticoid‐mediated osteoblast apoptosis

Espiña, B., Liang, M., Russell, R. G. G., & Hulley, P. A. (2007) · Journal of Cellular Physiology · doi:10.1002/jcp.21335 · Cited by 59 · see citing works

ABCC1 confers tissue-specific sensitivity to cortisol versus corticosterone: A rationale for safer glucocorticoid replacement therapy

Nixon, M., Mackenzie, S. D., Taylor, A. I., Homer, N. Z. M., Livingstone, D. E., Mouras, R., Morgan, R. A., Mole, D. J., Stimson, R. H., Reynolds, R. M., et al. (2016) · Science Translational Medicine · doi:10.1126/scitranslmed.aaf9074 · Cited by 59 · see citing works

Activation of dimeric glucocorticoid receptors in osteoclast progenitors potentiates RANKL induced mature osteoclast bone resorbing activity

Conaway, H. H., Henning, P., Lie, A., Tuckermann, J. P., & Lerner, U. H. (2016) · Bone · doi:10.1016/j.bone.2016.08.024 · Cited by 57 · see citing works

Adrenal incidentaloma

Sherlock, M., Scarsbrook, A., Abbas, A., Fraser, S., Limumpornpetch, P., Dineen, R., & Stewart, P. M. (2020) · Endocrine Reviews · doi:10.1210/endrev/bnaa008 · Cited by 347 · see citing works

Molecular Mechanisms of Glucocorticoid-Induced Insulin Resistance

Beaupere, C., Liboz, A., Fève, B., Blondeau, B., & Guillemain, G. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22020623 · Cited by 271 · see citing works

Pathophysiology and treatment of osteoporosis: Challenges for clinical practice in older people

Barnsley, J., Buckland, G., Chan, P. E., Ong, A., Ramos, A. S., Baxter, M., Laskou, F., Dennison, E. M., Cooper, C., & Patel, H. P. (2021) · Aging Clinical and Experimental Research · doi:10.1007/s40520-021-01817-y · Cited by 199 · see citing works

Pathogenic mechanisms of glucocorticoid-induced osteoporosis

Chen, M., Fu, W., Xu, H., & Liu, C.-J. (2023) · Cytokine &amp; Growth Factor Reviews · doi:10.1016/j.cytogfr.2023.03.002 · Cited by 146 · see citing works

Bone disease following solid organ transplantation: A narrative review and recommendations for management from The European Calcified Tissue Society

Anastasilakis, A. D., Tsourdi, E., Makras, P., Polyzos, S. A., Meier, C., McCloskey, E. V., Pepe, J., & Zillikens, M. C. (2019) · Bone · doi:10.1016/j.bone.2019.07.006 · Cited by 71 · see citing works

Long-term consequences of Cushing syndrome: a systematic literature review

Puglisi, S., Perini, A. M. E., Botto, C., Oliva, F., & Terzolo, M. (2024) · The Journal of Clinical Endocrinology &amp; Metabolism · doi:10.1210/clinem/dgad453 · Cited by 53 · see citing works

Excess glucocorticoids inhibit murine bone turnover via modulating the immunometabolism of the skeletal microenvironment

Li, X., Liang, T., Dai, B., Chang, L., Zhang, Y., Hu, S., Guo, J., Xu, S., Zheng, L., Yao, H., et al. (2024) · Journal of Clinical Investigation · doi:10.1172/jci166795 · Cited by 41 · see citing works

A review of mathematical modeling of bone remodeling from a systems biology perspective

Cook, C. V., Lighty, A. M., Smith, B. J., & Ford Versypt, A. N. (2024) · Frontiers in Systems Biology · doi:10.3389/fsysb.2024.1368555 · Cited by 25 · see citing works

miR-27a promotes osteogenic differentiation in glucocorticoid-treated human bone marrow mesenchymal stem cells by targeting PI3K

Tang, J., Yu, H., Wang, Y., Duan, G., Wang, B., Li, W., & Zhu, Z. (2021) · Journal of Molecular Histology · doi:10.1007/s10735-020-09947-9 · Cited by 16 · see citing works

Giucocorticoid-Insensitive Bronchial Asthma

Lee, T. H., & Leung, D. Y. M. (2008) · Blackwell Science Ltd eBooks · doi:10.1002/9780470694923.ch33

[Medicinal activation and inhibition of function of glucocorticoid receptors as the basis for regulation of the glucocorticoid effect].

Pp, G. (1994) · PubMed · Cited by 1 · see citing works

Study on the Relationship Between Sensitivity to Glucocorticoid and Glucocorticoid Receptor Isoform in Patients with Idiopathic Thrombocytopenia Purpura

Zhu, Q. H. (2007) · Chinese Journal of Thrombosis and Hemostasis

Heterogeneity of Binding Sites for Glucocorticoid and the Glucocorticoid-Receptor Complex in Rat Livers

Muramatsu, M., Tanaka, M., Fujita, A., et al. (1984) · The Japanese Journal of Pharmacology · doi:10.1254/jjp.36.87 · Cited by 1 · see citing works

The role of the glucocorticoid receptor and its impact on steroid response in moderate-severe COVID-19 patients

Aliska, G., Nafrialdi, N., Lie, K. C., Setiabudy, R., Putra, A. E., Widyahening, I. S., & Harahap, A. R. (2023) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2023.175555 · Cited by 7 · see citing works